09.09.15
Fremont, Calif.-based Nitinol Devices & Components Inc. (NDC) has completed the acquisition of Interface Catheter Solutions. Together, the companies will be renamed Confluent Medical Technologies, a company that makes specialized medical devices.
Interface is a contract manufacturer of balloon catheter systems, specializing in ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. NDC makes nitinol-based medical devices and components in the endovascular, peripheral vascular, cardiovascular and neurovascular spaces. The combined companies will focus particularly in the endovascular; neurovascular; transcatheter heart valve; peripheral vascular; ear, nose and throat; and orthopedic markets.
“The acquisition of Interface reflects our commitment to investing in material science technologies that enable us to best serve the medical device community,” said Dean Schauer, president/CEO of NDC. “The NDC-Interface combination is an excellent strategic fit.”
“It has long been a goal of NDC to apply its manufacturing, quality systems and technical expertise beyond nitinol, broadening the manufacturing and outsourcing solutions we can offer to customers,” said NDC’s Chief Technology Officer Tom Duerig. “The exceptional technical strength of Interface with polymers, catheters and balloons provides the perfect opportunity to accomplish just that.”
Interface is a contract manufacturer of balloon catheter systems, specializing in ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. NDC makes nitinol-based medical devices and components in the endovascular, peripheral vascular, cardiovascular and neurovascular spaces. The combined companies will focus particularly in the endovascular; neurovascular; transcatheter heart valve; peripheral vascular; ear, nose and throat; and orthopedic markets.
“The acquisition of Interface reflects our commitment to investing in material science technologies that enable us to best serve the medical device community,” said Dean Schauer, president/CEO of NDC. “The NDC-Interface combination is an excellent strategic fit.”
“It has long been a goal of NDC to apply its manufacturing, quality systems and technical expertise beyond nitinol, broadening the manufacturing and outsourcing solutions we can offer to customers,” said NDC’s Chief Technology Officer Tom Duerig. “The exceptional technical strength of Interface with polymers, catheters and balloons provides the perfect opportunity to accomplish just that.”